Search | IOVS | ARVO Journals

Showing 1 – 16 of 16

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Studies about the cooperative signaling between p75 NTR and Trk receptors in the modulation of choroidal neovascularization.

Paula Virginia Subirada Caldarone; Albana Tovo; María Victoria Vaglienti; Danisa Vicentin; Nicolás Ribotta; José Domingo Luna Pinto; Horacio Uri Saragovi; Maria Cecilia Sanchez; Agustin Anastasía; Pablo Federico Barcelona

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3030 – F0401. doi:

ARVO Annual Meeting Abstract June 2021

The neurotrophin receptor p75 NTR as a new player in the development of choroidal neovascularization

Paula Virginia Subirada Caldarone; Maria Victoria Vaglienti; Maria Paula O`brien; Alejandra Jurado; Jose D Luna Pinto; Horacio Uri Saragovi; Maria Cecilia Sanchez; Agustín Anastasía; Pablo Federico Barcelona

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):643. doi:

ARVO Annual Meeting Abstract June 2020

NEUROPROTECTIVE EFFECT OF MELATONIN LOADED IN ETHYLCELLULOSE NANOPARTICLES APPLIED TOPICALLY IN A RETINAL DEGENERATION MODEL IN RABBITS

Jose D Luna Pinto; Carolina del Valle Bessone; Sofía Mickaela Martinez; Marilyn Ann Marquez; Daniel Allemandi; Ágata Carpentieri; Daniela Quinteros

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2897. doi:

ARVO Annual Meeting Abstract July 2019

VALIDATION OF LASER-INDUCED CHOROIDAL NEOVASCULARIZATION (CNV) MOUSE MODEL: PARTICIPATION OF α 2 M/LRP1 SYSTEM

Pablo Federico Barcelona; Paula Subirada; Tomas Nabil Saddi; Marilyn Ann Marquez; Maria Victoria Vaglienti; Magali Evelin Ridano; Gabriel Marquez; Maria Constanza Paz; Jose D Luna Pinto; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1257. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of eplerenone versus melatonin as therapeutic options for the treatment of non-resolving and chronic central serous chorioretinopathy

Tomas Nabil Saddi; Juan Pablo Real; Eleonora Lavaque; Ana Laura Gramajo; Claudio Patricio Juarez; Ruth Estela Rosenstein; Jose D Luna Pinto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4078. doi:

ARVO Annual Meeting Abstract July 2018

Comparative study of VEGF inhibitors in Oxygen Induced Retinopathy (OIR) mouse model: Vascular, non-vascular and functional implications

Magali Evelin Evelin Ridano; Maria Constanza Paz; Paula Virginia Subirada; Jose D Luna Pinto; Diego Omar Croci Russo; Pablo Federico Barcelona; Maria Victoria Vaglienti; Gabriel Adrian Rabinovich; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6072. doi:

ARVO Annual Meeting Abstract June 2017

COMPARISON OF EPLERENONE VERSUS MELATONIN AS THERAPEUTIC OPTIONS FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Eleonora Beatriz Lavaque; Laura Gramajo; Juan Pablo Real; Claudio P Juarez; Ruth Estela Rosenstein; Jose D Luna Pinto

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5932. doi:

ARVO Annual Meeting Abstract June 2017

Use of discrete event simulation (DEM) to evaluate the clinical practices in neovascular age-related macular degeneration

Patricio Gerardo Schlottmann; Jose D Luna Pinto; Santiago Palma; Juan Pablo Real

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):428. doi:

ARVO Annual Meeting Abstract June 2017

Galectin-1 involvement in neovascular retinopathies

Magali Evelin Evelin Ridano; Paula Virginia Subirada Caldarone; Maria Constanza Paz; Valeria E Lorenc; Juan Carlos Stupirski; Laura Gramajo; Jose D Luna Pinto; Diego Omar Croci; Gabriel Adrian Rabinovich; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3596. doi:

ARVO Annual Meeting Abstract June 2017

THE rs4712527 POLYMORPHISM IN THE CDKAL1 GENE, AS A PROTECTIVE PREDICTOR OF PROLIFERATIVE DIABETIC RETINOPATHY DEVELOPMENT IN TYPE 2 DIABETIC PATIENTS.

Jose D Luna Pinto; Pablo Yang; Aylen Sein; Laura Gramajo; Emilia Aucar; Gabriel Marquez; Claudio P Juarez; Dante M Beltramo; Nestor W Soria

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1848. doi:

ARVO Annual Meeting Abstract September 2016

Non-vascular alterations and functional impairment persist after Anti-VEGF therapy in Oxygen Induced Retinopathy (OIR) mouse model

Magali Evelin Ridano; Valeria Erika Lorenc; Paula Subirada; Maria Constanza Paz; Diego Omar Croci Russo; Jose D Luna Pinto; Gabriel Adrián Rabinovich; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3636. doi:

ARVO Annual Meeting Abstract June 2015

Development of triamcionolone acetonide based lipid nanocapsules as platforms for ocular drug delivery

María Lina Formica; Gabriela Veronica Ullio Gamboa; Jean Pierre Benoit; Daniel Alberto Allemandi; Jose D Luna Pinto; Santiago Daniel Palma

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4152. doi:

ARVO Annual Meeting Abstract April 2014

IGF-1 regulates MMP2 activity in a hypoxia-independent manner in Müller Cells

Valeria Lorenc; Jose D Luna Pinto; Gustavo Chiabrando; Maria Cecilia Sanchez

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1347. doi:

ARVO Annual Meeting Abstract April 2014

Correlation between changes in visual acuity and time in age-related macular degeneration

Juan Pablo Real; Santiago Palma; Gladys Granero; Claudio P Juarez; Jose D Luna Pinto

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):602. doi:

ARVO Annual Meeting Abstract April 2014

POTENTIAL THERAPEUTIC BENEFIT OF MELATONIN IN REFRACTORY CENTRAL SEROUS CHORIORETINOPATHY

Jose D Luna Pinto; Ana L Gramajo; Gabriel Marquez; Victor Torres; Claudio P Juarez; Ruth Estela Rosenstein

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6374. doi:

ARVO Annual Meeting Abstract April 2011

Ocular Biocompatibility Of SC230 Celcuat Gel: Functional And Morphological Results

Jose D. Luna Pinto; Luciana G. Garcia; Ana L. Gramajo; Valeria Alacino; Juan P. Pusterla; Claudio P. Juarez; Hugo M. Fajreldines; Dante M. Beltramo

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5678. doi:

NARROW

Content Type

Journal

Article Type

Specify Date Range

Studies about the cooperative signaling between p75 NTR and Trk receptors in the modulation of choroidal neovascularization.

The neurotrophin receptor p75 NTR as a new player in the development of choroidal neovascularization

NEUROPROTECTIVE EFFECT OF MELATONIN LOADED IN ETHYLCELLULOSE NANOPARTICLES APPLIED TOPICALLY IN A RETINAL DEGENERATION MODEL IN RABBITS

VALIDATION OF LASER-INDUCED CHOROIDAL NEOVASCULARIZATION (CNV) MOUSE MODEL: PARTICIPATION OF α 2 M/LRP1 SYSTEM

Comparison of eplerenone versus melatonin as therapeutic options for the treatment of non-resolving and chronic central serous chorioretinopathy

Comparative study of VEGF inhibitors in Oxygen Induced Retinopathy (OIR) mouse model: Vascular, non-vascular and functional implications

COMPARISON OF EPLERENONE VERSUS MELATONIN AS THERAPEUTIC OPTIONS FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

Use of discrete event simulation (DEM) to evaluate the clinical practices in neovascular age-related macular degeneration

Galectin-1 involvement in neovascular retinopathies

THE rs4712527 POLYMORPHISM IN THE CDKAL1 GENE, AS A PROTECTIVE PREDICTOR OF PROLIFERATIVE DIABETIC RETINOPATHY DEVELOPMENT IN TYPE 2 DIABETIC PATIENTS.

Non-vascular alterations and functional impairment persist after Anti-VEGF therapy in Oxygen Induced Retinopathy (OIR) mouse model

Development of triamcionolone acetonide based lipid nanocapsules as platforms for ocular drug delivery

IGF-1 regulates MMP2 activity in a hypoxia-independent manner in Müller Cells

Correlation between changes in visual acuity and time in age-related macular degeneration

POTENTIAL THERAPEUTIC BENEFIT OF MELATONIN IN REFRACTORY CENTRAL SEROUS CHORIORETINOPATHY

Ocular Biocompatibility Of SC230 Celcuat Gel: Functional And Morphological Results

To View More...

You must be signed into an individual account to use this feature.